Preclinical development of a B7-H3-targeting ADC with a novel DNA topoisomerase I inhibitor for solid tumors

被引：0
|
作者：
Li, Chenggang
Yao, Jun
Qu, Chen
Li, Bing
Zhang, Yu
Shi, Rong
Qiu, Yang
Hua, Haiqing
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2967
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2967
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors
    Hurwitz, Herbert I.
    Cohen, Roger B.
    McGovren, J. Patrick
    Hirawat, Samit
    Petros, William P.
    Natsumeda, Yutaka
    Yoshinari, Tomoko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (01) : 139 - 147
  • [42] A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors
    Herbert I. Hurwitz
    Roger B. Cohen
    J. Patrick McGovren
    Samit Hirawat
    William P. Petros
    Yutaka Natsumeda
    Tomoko Yoshinari
    Cancer Chemotherapy and Pharmacology, 2007, 59 : 139 - 147
  • [43] Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial
    Vitanza, Nicholas A.
    Ronsley, Rebecca
    Choe, Michelle
    Seidel, Kristy
    Huang, Wenjun
    Rawlings-Rhea, Stephanie D.
    Beam, Madison
    Steinmetzer, Leonel
    Wilson, Ashley L.
    Brown, Christopher
    Beebe, Adam
    Lindgren, Catherine
    Gustafson, Joshua A.
    Wein, Amy
    Holtzclaw, Susan
    Hoeppner, Corrine
    Goldstein, Hannah E.
    Browd, Samuel R.
    Hauptman, Jason S.
    Lee, Amy
    Ojemann, Jeffrey G.
    Crotty, Erin E.
    Leary, Sarah E. S.
    Perez, Francisco A.
    Wright, Jason N.
    Alonso, Marta M.
    Dun, Matthew D.
    Foster, Jessica B.
    Hurst, Diana
    Kong, Ada
    Thomsen, Alison
    Orentas, Rimas J.
    Albert, Catherine M.
    Pinto, Navin
    Annesley, Colleen
    Gardner, Rebecca A.
    Ho, On
    Pattabhi, Sowmya
    Gust, Juliane
    Wendler, Jason P.
    Park, Julie R.
    Jensen, Michael C.
    NATURE MEDICINE, 2025, : 861 - 868
  • [44] Ifinatamab deruxtecan (I-DXd), a novel B7-H3-targeting antibody-drug conjugate, demonstrates efficient payload delivery into tumor through target-dependent internalization
    Katsumata, Len
    Deguchi, Tsuneo
    Hasegawa, Jun
    Yamato, Michiko
    Nishiya, Yumi
    Watanabe, Akiko
    Honda, Tomoyo
    Minami, Megumi
    Kasanuki, Naomi
    Maejima, Takanori
    Muramatsu, Sumie
    Herrmann, Monika
    Schulte, Nina
    Polier, Gernot
    Wang, Xuya
    Yoshida, Takanori
    Izumi, Nanae
    Qian, Xiaozhong
    Agatsuma, Toshinori
    Nakamaru, Kenji
    CANCER RESEARCH, 2023, 83 (07)
  • [45] DS-1062a, a novel TROP2-targeting antibody-drug conjugate with a novel DNA topoisomerase I inhibitor DXd, demonstrates potent antitumor activity in preclinical models
    Okajima, Daisuke
    Yamaguchi, Junko
    Kitamura, Michiko
    Kamei, Reiko
    Maejima, Takanori
    Shibutani, Tomoko
    Yasuda, Satoru
    Toki, Tadashi
    Karibe, Tsuyoshi
    Fujitani, Tomomichi
    Nakada, Takashi
    Goto, Riki
    Noguchi, Yutaka
    Abe, Yuki
    Agatsuma, Toshinori
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [46] ARTEMIS-001: Phase 1 study of HS-20093, a B7-H3-targeting antibody-drug conjugate, in patients with advanced solid tumor
    Wang, Jie
    Duan, Jianchun
    Xing, Ligang
    Sun, Yuping
    Guo, Wei
    Wang, Haiying
    Chen, Jianhua
    Han, Liang
    Liu, Baogang
    Wang, Qiming
    Hu, Ying
    Wei, Hongying
    Li, Chuan
    Huang, Qiqi
    Dong, Yiwei
    Wu, Qiong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [47] Tandem CAR-T cells targeting CD70 and B7-H3 exhibit potent preclinical activity against multiple solid tumors
    Yang, Meijia
    Tang, Xin
    Zhang, Zongliang
    Gu, Lei
    Wei, Heng
    Zhao, Shasha
    Zhong, Kunhong
    Mu, Min
    Huang, Cheng
    Jiang, Caiying
    Xu, Jianguo
    Guo, Gang
    Zhou, Liangxue
    Tong, Aiping
    THERANOSTICS, 2020, 10 (17): : 7622 - 7634
  • [48] DS-6000a, a novel CDH6-targeting antibody-drug conjugate with a novel DNA topoisomerase I inhibitor DXd, demonstrates potent antitumor activity in preclinical models
    Suzuki, H.
    Nagase, S.
    Saito, C.
    Nagata, M.
    Kaneda, Y.
    Honda, K.
    Nishiya, Y.
    Honda, T.
    Nakada, T.
    Goto, R.
    Ishizaka, T.
    Myobatake, Y.
    Abe, Y.
    Agatsuma, T.
    ANNALS OF ONCOLOGY, 2021, 32 : S363 - S364
  • [49] Development of novel topoisomerase 1 inhibitor PBX-7 payload-based ADC including tandem cleavable linker system
    Chun, Younghwa
    Go, Areum
    Cho, Hyun Yong
    Lee, Byeong Sung
    Shin, Seunggun
    Lee, JaeHyeon
    Kweon, Sohui
    Han, Hyemin
    Park, Suhyun
    Jung, Doo Young
    CANCER RESEARCH, 2024, 84 (06)
  • [50] Fully Human B7-H3 CAR T Cells Exhibit Potent Preclinical Activity Against Solid Tumors
    Bajgain, Pradip
    MOLECULAR THERAPY, 2024, 32 (04) : 402 - 402
12345